Dmitry Samarsky
Technik-/Wissenschafts-/F&E-Leiter bei SIRNAOMICS LTD.
Profil
Dmitry Samarsky is currently a Member at the University of Massachusetts Medical School, an Advisory Board Member at RusBioVentures LLC, and the Chief Technology Officer at Sirnaomics Ltd.
In the past, he worked as the Director of Technology Development at Dharmacon, Inc., Manager of Business Development at Invitrogen Corp., Vice President of Technology Development at Galena Biopharma, Inc., Principal at Sequitur, Inc., and Principal at Howard Hughes Medical Institute, Inc. He also served as the Senior VP of International Business Development at Guangzhou Ribobio Co., Ltd.
and held senior positions at OliX Pharmaceuticals, Inc. and Silence Therapeutics GmbH.
Dr. Samarsky earned his doctorate degree from the University of Massachusetts and his undergraduate degree from Lviv University.
Aktive Positionen von Dmitry Samarsky
| Unternehmen | Position | Beginn |
|---|---|---|
| SIRNAOMICS LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
| UMass Chan Medical School | Corporate Officer/Principal | - |
RusBioVentures LLC
 RusBioVentures LLC Investment ManagersFinance RusBioVentures LLC (RBV Capital) is a venture capital firm founded in 2014 by Alexey Konov. The firm is headquartered in Moscow, Russia. | Berater | - |
Ehemalige bekannte Positionen von Dmitry Samarsky
| Unternehmen | Position | Ende |
|---|---|---|
| Guangzhou Ribobio Co., Ltd. | Corporate Officer/Principal | 01.01.2015 |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Corporate Officer/Principal | - |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Corporate Officer/Principal | 01.01.2005 |
Sequitur, Inc.
 Sequitur, Inc. Miscellaneous Commercial ServicesCommercial Services Sequitur, Inc. provided drug discovery and disease research services. The company was headquartered in Huntington Beach, CA. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Dmitry Samarsky
| University of Massachusetts | Doctorate Degree |
| Lviv University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OLIX PHARMACEUTICALS, INC | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Sequitur, Inc.
Sequitur, Inc. Miscellaneous Commercial ServicesCommercial Services Sequitur, Inc. provided drug discovery and disease research services. The company was headquartered in Huntington Beach, CA. | Commercial Services |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Commercial Services |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
| Guangzhou Ribobio Co., Ltd. | |
RusBioVentures LLC
RusBioVentures LLC Investment ManagersFinance RusBioVentures LLC (RBV Capital) is a venture capital firm founded in 2014 by Alexey Konov. The firm is headquartered in Moscow, Russia. | Finance |
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Health Technology |
